Home / Clinical Decision Support & Reference / ActivSight Intelligent Light

ActivSight Intelligent Light

by Activ Surgical · Based in United States → — Intraoperative Intelligence Brings Infinite Possibilities. See Beyond.

Colorectal Surgery General Surgery Urology

Website

Claim this tool

Is this the maker? Claim the company →

Leave this field empty

Correct company / maker

Company website (optional)

Anything else? (optional)

Subscription-based cost of ownership

Regulatory Status Disclosed

Overview

Activ Surgical is a pioneering digital surgery company focused on improving surgical efficiency, accuracy, patient outcomes, and accessibility for both endoscopic and robotically-assisted procedures. Their first product, ActivSight™ Intelligent Light, provides visual insights and information to surgeons in real-time, enabling them to view critical physiological structures and functions unseen with the naked eye. This is achieved by leveraging augmented reality (AR), artificial intelligence (AI), machine learning (ML), and sensing-based technologies through their ActivEdge™ Platform. Activ Surgical aims to transform the collective surgical experience by delivering intelligent information that reduces surgical complication rates, ushering in a new standard of patient care and safety.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

Real-time intraoperative visual insights and data
Augmented reality overlays
Dye-free ActivPerfusionu2122 mode for tissue perfusion assessment
ActivICGu2122 mode for visualizing ICG in critical structures like bile ducts
MIS System Compatible (works with existing laparoscopic and robotic systems)
Modular form-factor with multimodal Advanced Visualization
Reduces cognitive burden for surgeons with AI mode
Hardware agnostic
Enhances patient care and safety

Use Cases

Evaluating tissue perfusion in colorectal surgery for anastomoses
Assessing tissue viability in esophagectomy during thoracic procedures
Evaluating small bowel ischemia in revisional bariatric procedures
Identifying and visualizing biliary anatomy and gallbladder in cholecystectomy
Enhancing intraoperative decision-making to reduce surgical complications
Providing real-time, on-demand perfusion assessment without dyes

What Physicians Need to Know

Evidence Base

ActivSight utilizes Laser Speckle Contrast Imaging (LSCI) and Near-Infrared Fluorescence (NIRF) with Indocyanine Green (ICG) to provide real-time tissue perfusion and critical structure identification. Studies have compared LSCI to ICG, highlighting LSCI's superior temporal accuracy, objectivity, repeatability, and lack of false positives due to dye retention. The technology is designed to address costly complications in surgeries like colorectal, bariatric, and esophagectomy, where leak rates can be significant.

Clinical Validation Studies

ActivSight has undergone clinical validation, including first-in-human/IRB studies and successful clinical use in over 200 patients across major hospital networks in the U.S. and Europe. A clinical study at The Ohio State University Wexner Medical Center demonstrated that ActivSight's advanced visualization impacted intraoperative surgical decision-making in 17.5% of minimally invasive left-sided colorectal cases. In these cases, the average discordance between the line of demarcation in white light imaging and LSCI was 3.7cm. The ICG and LSCI line of demarcation were concordant in 95% of cases. Another study showed 100% accuracy in identifying compromised perfusion and detecting perfusion differences, with surgeons recommending against anastomosis creation based on the visual feedback in cases of compromised perfusion. ActivSight received FDA 510(k) clearance in 2021 and CE Mark approval in 2022.

Alert Fatigue Management

The colorectal AI mode within ActivSight is designed to minimize cognitive burden for the surgeon by isolating the ActivPerfusion display to the targeted tissue, removing distractions from non-bowel tissue. This focused approach aims to reduce extraneous visual information, which can contribute to alert fatigue.

Override Rate Data

In a clinical study, surgeons changed an intraoperative decision in 17.5% of cases based on information provided by ActivSight's advanced visualization. This indicates a significant influence on surgical decisions, suggesting a high acceptance and utility of the provided insights.

Clinical Workflow Integration

ActivSight is designed as an easy-to-adapt, modular form-factor that seamlessly attaches to existing laparoscopic and robotic systems and integrates with standard monitors. It allows surgeons to switch between different visualization modes with the press of a button. The system requires no capital purchase, operating on a subscription-based cost of ownership, making it a routine part of surgical practice.

Physician Tip

ActivSight offers real-time, dye-free tissue perfusion assessment (ActivPerfusion Mode) and ICG visualization (ActivICG Mode), which can be critical for identifying vital structures and assessing tissue viability during minimally invasive procedures. Pay close attention to the augmented reality overlays, especially in the AI-enabled colorectal mode, as it can significantly enhance your perception of tissue perfusion and potentially alter intraoperative decisions, leading to improved patient outcomes and reduced complications. The system's ease of integration with existing equipment makes it a straightforward addition to current surgical workflows.

ActivSight is engineered for broad compatibility, integrating with existing laparoscopic and robotic surgical systems. It functions as a modular add-on, connecting to standard laparoscopic cameras and scopes, and utilizes the existing white light source while adding its coherent laser light for advanced imaging. The output is displayed on standard surgical monitors, ensuring seamless incorporation into the operating room setup.

At a glance

Pricing Subscription-based cost of ownership

Deployment On Premise (integrates With Existing Surgical Systems)

Visit site

Details

Category	Clinical Decision Support & Reference, Radiology & Imaging AI, Surgical AI
Pricing	Subscription-based cost of ownership — ActivSight requires no capital purchase with a subscription-based cost of ownership.
Deployment	On-premise (integrates with existing surgical systems)
Compliance
BAA Available	Unknown AI-estimated
HIPAA Compliant	Unknown AI-estimated
FDA Status	1 AI-estimated ActivSight received U.S. Food and Drug Administration (FDA) 510(k) clearance in 2021 for its intraoperative imaging module for enhanced surgical visualization.
Integrations
EHR	Not specified
Specialties	Colorectal Surgery, General Surgery, Urology

What the Web Says

ActivSight Intelligent Light is a modular imaging system designed to enhance visualization and provide real-time, on-demand surgical insights during minimally invasive procedures. It utilizes laser speckle contrast imaging (LSCI) for dye-free tissue perfusion assessment and also supports Indocyanine Green (ICG) visualization. Physicians have reported that ActivSight's advanced visualization capabilities can influence intraoperative decision-making and potentially lead to improved patient outcomes by reducing complications.

Overall: Positive

Strengths

Provides dye-free, real-time tissue perfusion information.
Offers enhanced visualization beyond the human visual spectrum.
Can influence intraoperative surgical decision-making.
Comparable to ICG for perfusion visualization, with the added benefit of being dye-less and repeatable.
Seamlessly attaches to existing laparoscopic and robotic systems.
Designed for ease of use with real-time data access at the push of a button.

Limitations

No specific cons were found in the provided search results from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra.
Limited independent reviews from diverse sources like G2, Capterra, or Reddit were available, with most information coming from company announcements and studies.
The available information primarily highlights positive outcomes from studies and expert opinions affiliated with Activ Surgical.

Based on reviews from: Activ Surgical (Company Announcements), The Ohio State University Wexner Medical Center (Clinical Studies), The American Society of Colon and Rectal Surgeons (ASCRS) Annual Scientific Meeting (Presentations), Surgical Endoscopy (Peer-Reviewed Publication), The Robot Report (Tech News), Nasdaq (Company News), MTEC (Company Profile), Medbionix (Product Information), YouTube (Presentation)

Last updated: 2026-09-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate ActivSight Intelligent Light

Clinical Value

Ease of Use

Integration

Support & Docs

Value for Money

Your Name *

Email *

Your Role

Specialty

Your Review * (min 50 characters)

Press & Coverage

Business Wire

Activ Surgical Announces Completion of First International Procedure Using Its ActivSightu2122 Intelligent Light

Activ Surgical announced the completion of its first international surgery using ActivSightu2122 Intelligent Light at Abdali Hospital in Amman, Jordan, aiming to provide enhanced visualization and real-time surgical insights. The ActivSight module seamlessly attaches to existing laparoscopic and robotic systems, integrating with standard monitors.

2024-01

Activ Surgical

Activ Surgical Announces Completion of First AI-Enabled Case Using Its ActivSightu2122Intelligent Light

Activ Surgical completed its first AI-enabled case using ActivSightu2122 Intelligent Light at The Ohio State University Wexner Medical Center, utilizing a proprietary colorectal AI mode for enhanced visualization and real-time surgical insights. The ActivSight module, cleared by the FDA in 2021 and CE Mark approved in 2022, provides augmented reality overlays for critical intraoperative visual data.

2023-01

The Robot Report

Activ Surgical completes first case with ActivSight

Activ Surgical announced the completion of its first case with ActivSight Intelligent Light, a module that enhances visualization during surgery, performed at the Ohio State University Wexner Medical Center. The surgery utilized ActivSight's dye-free ActivPerfusion Mode and colorectal AI mode to provide clear visualization of critical structures and tissue perfusion.

2023-01

Activ Surgical

Activ Surgical Secures CE Mark Approval for ActivSightu2122 Intelligent Light

Activ Surgical received CE Mark approval for its ActivSightu2122 Intelligent Light, validating its compliance with European Medical Devices Regulation and allowing commercialization in the EU. ActivSight is a modular system that attaches to laparoscopic systems, offering real-time, on-demand surgical insights through augmented reality overlays.

2022-12

Activ Surgical

Activ Surgical Celebrates First Peer-Reviewed Publication in Surgical Endoscopy for Study Using ActivSightu2122 Intelligent Light

Activ Surgical announced its first peer-reviewed study, published in Surgical Endoscopy, which investigated ActivSightu2122 Intelligent Light's use of laser speckle contrast imaging (LSCI) for real-time intraoperative tissue blood flow and perfusion. The study concluded that LSCI significantly improves the precision and accuracy of perfusion detection compared to indocyanine green (ICG) fluorescence.

2022-09

Activ Surgical

Activ Surgical Presented Findings from Colorectal Study Using its ActivSightu2122 Intelligent Light at the ASCRS Annual Scientific Meeting

Activ Surgical presented findings from a colorectal study at the ASCRS Annual Scientific Meeting, demonstrating that ActivSightu2122 Intelligent Light's advanced visualization, particularly its ActivPerfusionu2122 Mode, led to surgeons changing intraoperative decisions in 17.5% of cases. The study highlighted the value of dye-free, real-time tissue perfusion information for improved surgical outcomes.

2023-06

PR Newswire

Activ Surgical Introduces ActivInsights Augmented Reality Software Suite to Enhance Safety in the Operating Room

Activ Surgical introduced its ActivInsightsu2122 software suite, an augmented reality-based bundle offering real-time tissue assessment through visual overlays, as the first commercially available product of its ActivEdgeu2122 platform. This suite, combined with the ActivSightu2122 imaging module, aims to provide surgeons with real-time guidance and enhance safety in the operating room.

2021-06

accessdata.fda.gov

FDA 510(k) Clearance for ActivSight Intraoperative Imaging System

The FDA granted 510(k) clearance to the ActivSight Intraoperative Imaging System, an accessory to existing laparoscopic systems, for real-time endoscopic fluorescence and near-infrared imaging. This allows surgeons to visually assess vessels, blood flow, tissue perfusion, and major bile ducts during minimally invasive surgery.

2021-03

Videos

Product demos, reviews, and walkthroughs for ActivSight Intelligent Light.

Ep7 - Clip2 - Laser speckle technology to show active blood flow

Less Invasive Podcast

View all on YouTube

Frequently Asked Questions

How does ActivSight Intelligent Light enhance clinical decision-making during surgery?

ActivSight Intelligent Light provides real-time, enhanced visualization of tissue perfusion and anatomy, potentially allowing surgeons to make more informed decisions regarding tissue viability, critical structure identification, and the extent of resection. This can lead to improved patient outcomes by reducing complications related to ischemia or inadvertent tissue damage.

What are the compliance requirements and training necessary to integrate ActivSight into my surgical practice?

Integrating ActivSight typically involves a review of its regulatory clearances and understanding its indications for use. Training usually covers proper system setup, operation, interpretation of the visual feedback, and maintenance, often provided by the manufacturer to ensure safe and effective utilization within your existing surgical workflows.

Are there any comparable alternatives to ActivSight Intelligent Light for real-time tissue assessment, and how does it differentiate itself?

While other technologies offer various forms of tissue assessment, ActivSight differentiates itself through its specificu5149u8c31 imaging capabilities and integration with existing surgical platforms. Alternatives might include other fluorescence imaging systems or technologies focused on different physiological parameters, each with its own advantages and limitations.

What is the typical cost associated with acquiring and maintaining ActivSight Intelligent Light, and is it covered by insurance or reimbursement codes?

The cost of ActivSight involves the initial capital expenditure for the system and ongoing costs for consumables and service agreements. Reimbursement for procedures utilizing ActivSight can vary, and it's crucial to investigate specific CPT codes and insurance coverage policies relevant to your practice and patient population.

What are the known limitations or contraindications for using ActivSight Intelligent Light in various surgical specialties?

Limitations of ActivSight may include factors such as tissue depth penetration, interference from certain medical conditions or medications, and the learning curve associated with interpreting the enhanced visualization. Specific contraindications would be outlined in the device's official documentation and should be carefully reviewed for each surgical specialty.

Can ActivSight Intelligent Light be integrated with our existing operating room equipment and imaging systems?

ActivSight is designed for integration with compatible surgical platforms and imaging systems. Compatibility details are typically provided by the manufacturer, and it's important to assess your current OR setup to ensure seamless incorporation and functionality.

What kind of evidence supports the clinical efficacy and improved patient outcomes when using ActivSight Intelligent Light?

Clinical efficacy of ActivSight is supported by studies and data demonstrating its ability to enhance visualization of tissue perfusion and critical structures. This evidence often includes improvements in surgical precision, reduction in complication rates, and potentially shorter recovery times, which contribute to better patient outcomes.